The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Generic Sterile Injectable-Global Market Insights and Sales Trends 2025

Generic Sterile Injectable-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1822804

No of Pages : 103

Ask Your Query
Synopsis
The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.

The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.
The global Generic Sterile Injectable market size is expected to reach US$ 78570 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Generic Sterile Injectable in various end use industries. The expanding demands from the Hospitals, Pharmacies and Online Pharmacies,, are propelling Generic Sterile Injectable market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cytokines segment is estimated at % CAGR for the next seven-year period.
An alternative to the oral delivery mechanism is injectable drug delivery, which easily transports a drug dose through the bloodstream, thereby bypassing first-pass metabolism. There are some medications that would be entirely useless if delivered as capsules, as they would be killed by enzymes that digest food in the stomach. The insulin injection used in diabetes care is an example. Insulin is a protein. Therefore, if given as a tablet, the same enzymes that ferment food in the stomach would be digested. Therefore, as of today, there is no such term as an insulin tablet. Injectable allow the transport, directly into the bloodstream, of drugs manufactured in liquid form. The goal of the delivery of injectable drugs is to optimize patient compliance and reduce the frequency of dose administration without reducing medication efficacy. Due to deep vomiting, unconsciousness or having a cancer lining in the upper part of their dietary canal, it may be impossible to take tablets for certain patients. Therefore, injection options are available for most oral medications. The increasing prevalence of such metabolic disease aids in the overall growth in the sterile injectable market.

Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Generic Sterile Injectable, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Generic Sterile Injectable market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Generic Sterile Injectable market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Generic Sterile Injectable sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Generic Sterile Injectable covered in this report include 3M, Baxter Inc, Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma and Dr. Reddy’s, etc.
The global Generic Sterile Injectable market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy’s
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab
Global Generic Sterile Injectable market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Generic Sterile Injectable market, Segment by Type:
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Others
Global Generic Sterile Injectable market, by Application
Hospitals
Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Generic Sterile Injectable manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Generic Sterile Injectable in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Generic Sterile Injectable Market Overview
1.1 Generic Sterile Injectable Product Overview
1.2 Generic Sterile Injectable Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Cytokines
1.2.3 Insulin
1.2.4 Peptide Hormones
1.2.5 Vaccines
1.2.6 Others
1.3 Global Generic Sterile Injectable Market Size by Type
1.3.1 Global Generic Sterile Injectable Market Size Overview by Type (2018-2029)
1.3.2 Global Generic Sterile Injectable Historic Market Size Review by Type (2018-2023)
1.3.3 Global Generic Sterile Injectable Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
1.4.2 Europe Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Generic Sterile Injectable Sales Breakdown by Type (2018-2023)
2 Global Generic Sterile Injectable Market Competition by Company
2.1 Global Top Players by Generic Sterile Injectable Sales (2018-2023)
2.2 Global Top Players by Generic Sterile Injectable Revenue (2018-2023)
2.3 Global Top Players by Generic Sterile Injectable Price (2018-2023)
2.4 Global Top Manufacturers Generic Sterile Injectable Manufacturing Base Distribution, Sales Area, Product Type
2.5 Generic Sterile Injectable Market Competitive Situation and Trends
2.5.1 Generic Sterile Injectable Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Generic Sterile Injectable Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Sterile Injectable as of 2022)
2.7 Date of Key Manufacturers Enter into Generic Sterile Injectable Market
2.8 Key Manufacturers Generic Sterile Injectable Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Generic Sterile Injectable Status and Outlook by Region
3.1 Global Generic Sterile Injectable Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Generic Sterile Injectable Historic Market Size by Region
3.2.1 Global Generic Sterile Injectable Sales in Volume by Region (2018-2023)
3.2.2 Global Generic Sterile Injectable Sales in Value by Region (2018-2023)
3.2.3 Global Generic Sterile Injectable Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Generic Sterile Injectable Forecasted Market Size by Region
3.3.1 Global Generic Sterile Injectable Sales in Volume by Region (2024-2029)
3.3.2 Global Generic Sterile Injectable Sales in Value by Region (2024-2029)
3.3.3 Global Generic Sterile Injectable Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Generic Sterile Injectable by Application
4.1 Generic Sterile Injectable Market Segment by Application
4.1.1 Hospitals
4.1.2 Pharmacies
4.1.3 Online Pharmacies
4.2 Global Generic Sterile Injectable Market Size by Application
4.2.1 Global Generic Sterile Injectable Market Size Overview by Application (2018-2029)
4.2.2 Global Generic Sterile Injectable Historic Market Size Review by Application (2018-2023)
4.2.3 Global Generic Sterile Injectable Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
4.3.2 Europe Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Generic Sterile Injectable Sales Breakdown by Application (2018-2023)
5 North America Generic Sterile Injectable by Country
5.1 North America Generic Sterile Injectable Historic Market Size by Country
5.1.1 North America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Generic Sterile Injectable Sales in Volume by Country (2018-2023)
5.1.3 North America Generic Sterile Injectable Sales in Value by Country (2018-2023)
5.2 North America Generic Sterile Injectable Forecasted Market Size by Country
5.2.1 North America Generic Sterile Injectable Sales in Volume by Country (2024-2029)
5.2.2 North America Generic Sterile Injectable Sales in Value by Country (2024-2029)
6 Europe Generic Sterile Injectable by Country
6.1 Europe Generic Sterile Injectable Historic Market Size by Country
6.1.1 Europe Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Generic Sterile Injectable Sales in Volume by Country (2018-2023)
6.1.3 Europe Generic Sterile Injectable Sales in Value by Country (2018-2023)
6.2 Europe Generic Sterile Injectable Forecasted Market Size by Country
6.2.1 Europe Generic Sterile Injectable Sales in Volume by Country (2024-2029)
6.2.2 Europe Generic Sterile Injectable Sales in Value by Country (2024-2029)
7 Asia-Pacific Generic Sterile Injectable by Region
7.1 Asia-Pacific Generic Sterile Injectable Historic Market Size by Region
7.1.1 Asia-Pacific Generic Sterile Injectable Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Generic Sterile Injectable Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Generic Sterile Injectable Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Generic Sterile Injectable Forecasted Market Size by Region
7.2.1 Asia-Pacific Generic Sterile Injectable Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Generic Sterile Injectable Sales in Value by Region (2024-2029)
8 Latin America Generic Sterile Injectable by Country
8.1 Latin America Generic Sterile Injectable Historic Market Size by Country
8.1.1 Latin America Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Generic Sterile Injectable Sales in Volume by Country (2018-2023)
8.1.3 Latin America Generic Sterile Injectable Sales in Value by Country (2018-2023)
8.2 Latin America Generic Sterile Injectable Forecasted Market Size by Country
8.2.1 Latin America Generic Sterile Injectable Sales in Volume by Country (2024-2029)
8.2.2 Latin America Generic Sterile Injectable Sales in Value by Country (2024-2029)
9 Middle East and Africa Generic Sterile Injectable by Country
9.1 Middle East and Africa Generic Sterile Injectable Historic Market Size by Country
9.1.1 Middle East and Africa Generic Sterile Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Generic Sterile Injectable Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Generic Sterile Injectable Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Generic Sterile Injectable Forecasted Market Size by Country
9.2.1 Middle East and Africa Generic Sterile Injectable Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Generic Sterile Injectable Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 3M
10.1.1 3M Company Information
10.1.2 3M Introduction and Business Overview
10.1.3 3M Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.1.4 3M Generic Sterile Injectable Products Offered
10.1.5 3M Recent Development
10.2 Baxter Inc
10.2.1 Baxter Inc Company Information
10.2.2 Baxter Inc Introduction and Business Overview
10.2.3 Baxter Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter Inc Generic Sterile Injectable Products Offered
10.2.5 Baxter Inc Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Fresenius Kabi Generic Sterile Injectable Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Pfizer/Hospira
10.4.1 Pfizer/Hospira Company Information
10.4.2 Pfizer/Hospira Introduction and Business Overview
10.4.3 Pfizer/Hospira Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer/Hospira Generic Sterile Injectable Products Offered
10.4.5 Pfizer/Hospira Recent Development
10.5 Novartis/Sandoz
10.5.1 Novartis/Sandoz Company Information
10.5.2 Novartis/Sandoz Introduction and Business Overview
10.5.3 Novartis/Sandoz Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis/Sandoz Generic Sterile Injectable Products Offered
10.5.5 Novartis/Sandoz Recent Development
10.6 Teva
10.6.1 Teva Company Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Generic Sterile Injectable Products Offered
10.6.5 Teva Recent Development
10.7 Hikma
10.7.1 Hikma Company Information
10.7.2 Hikma Introduction and Business Overview
10.7.3 Hikma Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hikma Generic Sterile Injectable Products Offered
10.7.5 Hikma Recent Development
10.8 Sun Pharma
10.8.1 Sun Pharma Company Information
10.8.2 Sun Pharma Introduction and Business Overview
10.8.3 Sun Pharma Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sun Pharma Generic Sterile Injectable Products Offered
10.8.5 Sun Pharma Recent Development
10.9 Dr. Reddy’s
10.9.1 Dr. Reddy’s Company Information
10.9.2 Dr. Reddy’s Introduction and Business Overview
10.9.3 Dr. Reddy’s Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Dr. Reddy’s Generic Sterile Injectable Products Offered
10.9.5 Dr. Reddy’s Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mylan Generic Sterile Injectable Products Offered
10.10.5 Mylan Recent Development
10.11 AstraZeneca Plc
10.11.1 AstraZeneca Plc Company Information
10.11.2 AstraZeneca Plc Introduction and Business Overview
10.11.3 AstraZeneca Plc Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.11.4 AstraZeneca Plc Generic Sterile Injectable Products Offered
10.11.5 AstraZeneca Plc Recent Development
10.12 Merck & Co., Inc
10.12.1 Merck & Co., Inc Company Information
10.12.2 Merck & Co., Inc Introduction and Business Overview
10.12.3 Merck & Co., Inc Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Merck & Co., Inc Generic Sterile Injectable Products Offered
10.12.5 Merck & Co., Inc Recent Development
10.13 Hellberg Safety Ab
10.13.1 Hellberg Safety Ab Company Information
10.13.2 Hellberg Safety Ab Introduction and Business Overview
10.13.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Hellberg Safety Ab Generic Sterile Injectable Products Offered
10.13.5 Hellberg Safety Ab Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Generic Sterile Injectable Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Generic Sterile Injectable Industrial Chain Analysis
11.4 Generic Sterile Injectable Market Dynamics
11.4.1 Generic Sterile Injectable Industry Trends
11.4.2 Generic Sterile Injectable Market Drivers
11.4.3 Generic Sterile Injectable Market Challenges
11.4.4 Generic Sterile Injectable Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Generic Sterile Injectable Distributors
12.3 Generic Sterile Injectable Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock